Stimulatory effects of the ionic products from Ca-Mg-Si bioceramics on both osteogenesis and angiogenesis in vitro

Acta Biomaterialia

Volumn 9, Issue 8, 2013, Pages 8004-8014

  Zhai, Wanyin ^a   Lu, Hongxu ^b   Wu, Chengtie ^a   Chen, Lei ^a   Lin, Xiaoting ^b   Naoki, Kawazoe ^b   Chen, Guoping ^b   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

Cell proliferation; Ion extracts; Osteogenesis; Silicate bioceramics; Silicon

Indexed keywords

BIOCERAMICS; BONE; CALCIUM COMPOUNDS; CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION; MAGNESIUM COMPOUNDS; PHOSPHATASES; SCAFFOLDS (BIOLOGY); SILICATES; SILICON; STEM CELLS; TRANSMISSION CONTROL PROTOCOL;

AKERMANITE; ANGIOGENESIS; BONE TISSUE ENGINEERING; BREDIGITE; IN-VITRO; ION EXTRACT; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; SILICATE BIOCERAMIC;

IONS;

AKERMANITE; ALKALINE PHOSPHATASE; BIOCERAMICS; BREDIGITE; CALCIUM; CALCIUM MAGNESIUM SILICATE; MAGNESIUM; SILICATE; SILICON; UNCLASSIFIED DRUG; AMPHIBOLE; BONE PROSTHESIS; CERAMICS; ION; TREMOLITE;

ACVRL1 GENE; ALPASE GENE; ANGIOGENESIS; AORTIC ENDOTHELIAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW MESENCHYMAL STEM CELL; COL1 GENE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FGFR1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KDR GENE; MESENCHYMAL STEM CELL; NOS3 GENE; OC GENE; OP GENE; PRIORITY JOURNAL; BONE PROSTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CERAMICS; CHEMISTRY; CYTOLOGY; MATERIALS TESTING; MESENCHYMAL STROMA CELL; OSTEOBLAST; PHYSIOLOGY; SYNTHESIS;

ASBESTOS, AMPHIBOLE; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMICS; ENDOTHELIAL CELLS; HUMANS; IONS; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOGENESIS;

EID: 84891454437     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.04.024     Document Type: Article

References (45)

1. Grifpth LG. Polymeric biomaterials. Acta Mater 2000;48:263-77.
2. Grifpth LG, Naughton G. Tissue engineering: current challenges and expanding opportunities. Science 2002;295:1009-14.
3. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of bioglass 45S5 dissolution. Biomed Mater Res 2001;55:151-7.
4. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-7.
5. Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng 2005;11:768-77.
6. Gorustovich AA, Perio C, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng B 2010;16:199-207.
7. Hoppe A, Güldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011;32:2757-74.
8. Wu C, Chang J. Degradation, bioactivity and cytocompatibility of diopside, akermanite, and bredigite ceramics. J Biomed Mater Res B Appl Biomater 2007;83:153-60.
9. Wu C, Chang J. A novel akermanite bioceramic: preparation and characteristics. J Biomater Appl 2006;21:119-29.
10. Wu C, Chang J, Ni S, Wang J. In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A 2006;76:73-80.
11. Wu C, Chang J, Zhai W, Ni S, Wang J. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. J Biomed Mater Res B Appl Biomater 2006;78:47-55.
12. Sun H, Wu C, Dai K, Chang J, Tang T. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanitebioactive ceramics. Biomaterials 2006;27:5651-7.
13. Huang Y, Jin X, Zhang X, Sun H, Tu J, Tang T, et al. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009;30:5041-8.
14. Liu Q, Cen L, Yin S, Chen L, Liu G, Chang J, et al. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials 2008;29:4792-9.
15. Gu H, Guo F, Zhou X, Gong L, Zhang Y, Zhai W, et al. The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway. Biomaterials 2011;32:7023-33.
16. Zhai W, Lu H, Chen L, Lin X, Huang Y, Dai K, et al. Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater 2012;8:341-9.
17. Wu CT, Chang J. Synthesis and apatite-formation ability of akermanite. Mater Lett 2004;58:2415-7.
18. Wu CT, Chang J. Synthesis and in vitro bioactivity of bredigite powders. J Biomater Appl 2007;21:251-63.
19. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-5.
20. Lu H, Kawazoe N, Tateishi T, Chen G. In vitro proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stem cells cultured with hardystonite (Ca2ZnSi2O7) and b-TCP ceramics. J Biomater Appl 2010;25:39-56.
21. de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, et al. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. PNAS 2010;107:14484-9.
22. Frank O, Heim M, Jakob M, Barbero A, Schafer D, Bendik I, et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 2002;85:737-46.
23. Schaefer JF, Millham ML, de Crombrugghe B, Buckbinder L. FGF signaling antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma cells. Osteoarthritis Cartilage 2003;11:233-41.
24. Planchet E, Kaiser WM. Nitric oxide (NO) detection by DAF fluorescence and chemiluminescence: a comparison using abiotic and biotic NO sources. J Exp Bot 2006;57:3043-55.
25. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T. Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed 1999;38:3209-12.
26. Heinke J, Wehofsits L, Zhou Q, Zoeller C, Baar KM, Helbing T, et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 2008;103:804-12.
27. Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. PNAS 2008;105:7738-43.
28. Xu S, Lin K, Wang Z, Chang J, Wang L, Lu J, et al. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials 2008;29:2588-96.
29. Cao LH, Yu BQ, Wu GS, Su JC. Study on adulterate sodium silica apatite cement porous scaffolds for bone defect repair. J Inorg Mater 2011;26:591-6.
30. Varanasi VG, Leong KK, Dominia LM, Jue SM, Loomer PM, Marshall GW, et al. Si and Ca individually and combinatorially target enhanced MC3T3-E1 subclone 4 early osteogenic marker expression. J Oral Implantol 2012;38:325-6.
31. Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 2003;32:127-35.
32. Duivenvoorden WC, Middleton A, Kinrade SD. Divergent effects of orthosilicic acid and dimethylsilanediol on cell survival and adhesion in human osteoblast-like cells. J Trace Elem Med Biol 2008;22:215-23.
33. Han P, Wu C, Xiao Y. The effect of silicate ions on proliferation, osteogenic differentiation and cell signalling pathways (WNT and SHH) of bone marrow stromal cells. Biomater Sci 2013;1:379-92.
34. Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging 2007;11(2):99-110.
35. Jugdaohsingh R, Calomme M, Robinson K, Nielsen F, Anderson SHC, D'Haese P, et al. Increased longitudinal growth in rats on a silicon-depleted diet. Bone 2008;43:596-606.
36. Yuan H, Yang Z, Bruijn JD, Groot K, Zhang X. Material-dependent bone induction by calcium phosphate ceramics: a 2.5-year study in dog. Biomaterials 2001;22:2617-23.
37. Henno JC, Lambotte D, Glez M, Guigand G, Lancien G, Cathelineau G. Characterisation and quantification of angiogenesis in b-tricalcium phosphate implants by immunohistochemistry and transmission electron microscopy. Biomaterials 2003;24:3173-81.
38. Leu A, Stieger SM, Dayton P, Ferrara KW, Leach JK. Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng A 2009;15:877-85.
39. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611.
40. Miller TW, Isenberg JS, Roberts DD. Molecular regulation of tumor angiogenesis and perfusion via redox signaling. Chem Rev 2009;109:3099-124.
41. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factorinduced angiogenesis and vascular permeability. PNAS 2001;98:2604-29.
42. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998;82:1007-15.
43. Santibanez JF, Letamendia A, Perez-Barriocanal F, Silvestri C, Saura M, Vary CPH, et al. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-b signaling. J Cell Physiol 2007;210:456-68.
44. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006;6:521-34.
45. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005;16:159-78.